# The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.

> **NCT07329998** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hillel Yaffe Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Oocyte Quality Assessment Using Spectrophotometer

## Interventions

- **PROCEDURE:** Oocyte quality assessment using spectrophotometer

## Key facts

- **NCT ID:** NCT07329998
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-22
- **Primary completion:** 2025-12-16
- **Final completion:** 2026-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07329998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07329998, "The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07329998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*